Kevin Rowland Email Address

President and Chief Executive Officer

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its

Biotech/Medtech CEO with deep experience leading companies in pre-clinical, clinical and commercial development of advanced, game-changing products in biologics, drug delivery and medical devices. Sets strategy and builds value in both emerging venture-backed and highly profitable businesses for health care market leaders. Instills strong corporate team culture by engaging talent, communicating a compelling strategy, and driving performance to build value. ✦ Proven commercial leadership and business success: Built from scratch and was General Manager with full P&L of high-growth $100 million-plus regenerative medicine business for a Fortune 500 health care leader. Targeted unmet needs through M&A, product/clinical/commercial development, and sales growth. ✦ Inspiring and entrepreneurial leadership: Most recently, transformed struggling venture-backed biotech by focusing strategy and coalescing team around an exciting vision. Drew major investments from premier venture funds, a strategic partner, and the Bill and Melinda Gates Foundation. ✦ Exemplary strategic and corporate development: Excels at building company value by creating visionary strategy, raising capital, recruiting loyal, world-class talent, establishing operational excellence, and driving fruitful partnerships/M&A. ✦ Deep technology expertise: Brings a unique combination of a Ph.D. in Materials Science and Engineering with business and R&D leadership, and extensive experience developing advanced medical device, regenerative medicine, and drug delivery products across multiple therapeutic spaces.